Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets
Clinical trial NCT01226056 · SUSPENDED
Trial details
- NCT number
- NCT01226056
- Sponsor
- Southern Europe New Drug Organization
- Status
- SUSPENDED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2012-09-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.